Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Curr Opin Crit Care ; 30(3): 224-230, 2024 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-38441086

RESUMO

PURPOSE OF REVIEW: With the return of international travels to almost prepandemic levels, the number of patients who travel abroad to seek healthcare services is once again growing rapidly. Nevertheless, the expected benefits of medical tourism may be challenged by serious infectious complications. This review summarizes the evolving published evidence on infectious complications related with medical tourism of the last eighteen months. RECENT FINDINGS: There has been an increase of reported infectious complications in patients who had received healthcare abroad. Such complications were frequently associated with serious and prolonged morbidity, repeated treatments and hospitalizations, high healthcare costs, and occasionally fatalities. A devastating outbreak of fungal meningitis occurred among US residents who underwent epidural anesthesia for cosmetic surgery in two clinics in Mexico. Overall, as of July 5, 2023 there were 31 cases with severe cerebrovascular complications and eight deaths. Infections caused by nontuberculum mycobacteria and Candida sp have been also reported the last years. SUMMARY: Considering the expected expansion of medical tourism in the forthcoming years, public health authorities and scientific societies should raise awareness of such infections among physicians and other healthcare professionals and issue recommendations for their management. A system to report complications in patients receiving healthcare abroad is needed.


Assuntos
Turismo Médico , Humanos
2.
Vaccine ; 40(40): 5752-5756, 2022 09 22.
Artigo em Inglês | MEDLINE | ID: mdl-36008235

RESUMO

AIM: To estimate neutralizing antibody (NAb) immunity against SARS-CoV-2 in 739 healthcare personnel (HCP) vaccinated with three doses of BNT162b2 mRNA vaccine. METHODS: Serum samples were collected at 3, 6, and 9 months after the second vaccine dose and at 7-55 days after the third dose. Samples were tested for NAbs against SARS-CoV-2 receptor binding domain. RESULTS: The mean inhibition rates at 3, 6, and 9 months after the second dose were 86.33%, 73.38%, and 61.18%, and increased to 95.57% after the booster dose. Younger HCP and HCP with past SARS-CoV-2 infection had higher inhibition rates while there was an inverse correlation between NAb levels and comorbidities or tobacco use (p-values < 0.001). Increased NAb titers were also noticed in women (p-value = 0.033), especially at the end of the 9-month study period. CONCLUSION: NAb levels increased considerably after a booster mRNA vaccine dose. Host factors and past SARS-CoV-2 infection influence NAb titers.


Assuntos
COVID-19 , Vacinas Virais , Anticorpos Neutralizantes , Anticorpos Antivirais , Vacina BNT162 , COVID-19/prevenção & controle , Atenção à Saúde , Feminino , Humanos , RNA Mensageiro , SARS-CoV-2 , Vacinas Sintéticas , Vacinas de mRNA
3.
Antibiotics (Basel) ; 11(8)2022 Aug 19.
Artigo em Inglês | MEDLINE | ID: mdl-36009998

RESUMO

Ventilator-associated pneumonia (VAP) occurs more than 48h after mechanical ventilation and is associated with a high mortality rate. The current hospital-based study aims to investigate the association between VAP rate, incidence of bacteremia from multidrug-resistant (MDR) pathogens, and infection control interventions in a single case mix ICU from 2013 to 2018. Methods: The following monthly indices were analyzed: (1) VAP rate; (2) use of hand hygiene disinfectants; (3) isolation rate of patients with MDR bacteria; and (4) incidence of bacteremia/1000 patient-days (total cases, total carbapenem-resistant cases, and carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae cases separately). Results: Time trends of infection control interventions showed increased rates in isolation of patients with MDR pathogens (p <0.001) and consumption of hand disinfectant solutions (p =0.001). The last four years of the study an annual decrease of VAP rate by 35.12% (95% CI: −53.52 to −9.41; p =0.01) was recorded, which significantly correlated not only with reduced trauma and cardiothoracic surgery patients (IRR:2.49; 95% CI: 2.09−2.96; p <0.001), but also with increased isolation rate of patients with MDR pathogens (IRR: 0.52; 95% CI: 0.27−0.99; p = 0.048), and hand disinfectants use (IRR: 0.40; 95% CI: 0.18−0.89; p =0.024). Conclusions: Infection control interventions significantly contributed to the decrease of VAP rate. Constant infection control stewardship has a stable time-effect and guides evidence-based decisions.

4.
Vaccine ; 40(2): 183-186, 2022 01 21.
Artigo em Inglês | MEDLINE | ID: mdl-34863620

RESUMO

We retrieved data on 8940 anaphylaxis cases post-COVID-19 vaccination from the US Vaccine Adverse Event Reporting System and the European EudraVigilance from week 52/2020 through week 31/2021 and compared them with those of other vaccines. Overall, 837,830,000 COVID-19 vaccine doses were delivered in the US and Europe during the study period, for which the vaccine name was known. The mean anaphylaxis rate was estimated at 10.67 cases per 106 doses of COVID-19 vaccines (range: 7.99-19.39 cases per 106 doses depending on the vaccine). COVID-19 vaccines ranked fifth in reported anaphylaxis rates, behind rabies, tick-borne encephalitis, measles-mumps-rubella-varicella, and human papillomavirus vaccines (70.77, 20, 19.8, and 13.65 cases per 106 vaccine doses, respectively). COVID-19 vaccines are within the range of anaphylaxis rates reported across several common vaccines in these two passive reporting systems. These data should be communicated to reassure the general population about the safety profile of COVID-19 vaccines.


Assuntos
Anafilaxia , COVID-19 , Anafilaxia/induzido quimicamente , Anafilaxia/epidemiologia , Vacinas contra COVID-19 , Humanos , Lactente , Vacina contra Sarampo-Caxumba-Rubéola/efeitos adversos , Vacina contra Caxumba , SARS-CoV-2
5.
J Travel Med ; 28(1)2021 01 06.
Artigo em Inglês | MEDLINE | ID: mdl-33159509

RESUMO

BACKGROUND: Medical tourism has been increasing dramatically globally, with people travelling from developed countries to low-income or middle-income countries, often to avoid high costs or long delays associated with seeking healthcare in their countries of origin. The current review summarizes healthcare-related infections associated with medical tourism, focusing on cosmetic surgery and organ transplantation. METHODS: A systematic MEDLINE and PubMed search from January 2010 to December 2019 yielded 80 relevant articles, including 49 articles on medical tourism-related infections focusing on cosmetic surgery and organ transplantation, which were included in this reviews. RESULTS: The literature reveals specific types of cross-border, healthcare-related infections depending on medical intervention. Destinations include low-income countries such as countries of Asia and the Indian subcontinent, middle-income countries including Central and South America, and high-income countries such as the United States and Europe. In terms of type of infections, in 36 (68%) and 15 (28.3%) studies, wound and blood-borne infections were documented, respectively, while in 21 studies (58.3%) non-tuberculous mycobacteria were isolated, including Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium senegalense and Mycobacterium fortuitum. The choices of medical tourists could have significant consequences for them and their home countries, including infectious complications and importation of pathogens, particularly antibiotic-resistant microorganisms, with public health implications. CONCLUSIONS: There is a need for public health strategies in order to prevent morbidity and mortality as well as future management and education of patients engaging in medical tourism.


Assuntos
Turismo Médico , Ásia , Europa (Continente) , Humanos , Mycobacteriaceae , América do Sul , Turismo , Estados Unidos
6.
Clin Infect Dis ; 71(12): 3182-3187, 2020 12 15.
Artigo em Inglês | MEDLINE | ID: mdl-32594160

RESUMO

BACKGROUND: As of late February 2020, Greece has been experiencing the coronavirus disease 2019 (COVID-19) epidemic. Healthcare personnel (HCP) were disproportionately affected, accounting for ~10% of notified cases. Exclusion from work for 7 days was recommended for HCP with high-risk occupational exposure. Our aim was to evaluate the 7-day exclusion from work policy for HCP with high-risk exposure. METHODS: HCP with a history of occupational exposure to COVID-19 were notified to the Hellenic National Public Health Organization, regardless of their exposure risk category. Exposed HCP were followed for 14 days after last exposure. RESULTS: We prospectively studied 3398 occupationally exposed HCP; nursing personnel accounted for most exposures (n = 1705; 50.2%). Of the 3398 exposed HCP, 1599 (47.1%) were classified as low-risk, 765 (22.5%) as moderate-risk, and 1031 (30.4%) as high-risk exposures. Sixty-six (1.9%) HCP developed COVID-19 at a mean of 3.65 (range: 0-17) days postexposure. Of the 66 HCP with COVID-19, 46, 7, and 13 had a history of high-, moderate- or low-risk exposure (4.5%, 0.9%, and 0.8% of all high-, moderate-, and low-risk exposures, respectively). Hospitalization and absenteeism were more prevalent among HCP with high-risk exposure. A logistic regression analysis showed that the following variables were significantly associated with an increased risk for the onset of COVID-19: male, administrative personnel, underlying disease, and high-risk exposure. CONCLUSIONS: HCP with high-risk occupational exposure to COVID-19 had increased probability of serious morbidity, healthcare seeking, hospitalization, and absenteeism. Our findings justify the 7-day exclusion from work policy for HCP with high-risk exposure.


Assuntos
COVID-19 , Exposição Ocupacional , Atenção à Saúde , Grécia , Pessoal de Saúde , Humanos , Masculino , Políticas , SARS-CoV-2
7.
Papillomavirus Res ; 8: 100183, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31476478

RESUMO

The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.


Assuntos
Pessoal de Saúde , Papillomaviridae/imunologia , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/imunologia , Europa (Continente)/epidemiologia , Conhecimentos, Atitudes e Prática em Saúde , Implementação de Plano de Saúde , Humanos , Infecções por Papillomavirus/complicações , Infecções por Papillomavirus/virologia , Vacinas contra Papillomavirus/administração & dosagem , Serviços Preventivos de Saúde , Vigilância em Saúde Pública , Vacinação
8.
Pediatr Infect Dis J ; 37(5): e132-e135, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-28885461

RESUMO

BACKGROUND: There are few publications focusing on vaccination and malaria chemoprophylaxis in adolescent travelers. We assessed pretravel vaccinations and malaria chemoprophylaxis of adolescents 12-18 years old traveling from Greece to international destinations. METHODS: We prospectively studied 239 adolescents 12-18 years old during 2008-2016. A standard questionnaire was used to collect data. RESULTS: Adolescents sought pretravel services at a mean of 24.1 days before departure. Their main destinations were sub-Saharan Africa (79 adolescents; 33.1%), Latin America (56; 23.5%) and North America (26; 10.9%). Almost half (46.1%) of them planned to stay abroad for at least 3 months. Sixteen (7.4%) adolescents planned to visit friends and relatives. The yellow fever vaccine and the typhoid vaccine were the most frequently administered vaccines (74.1% and 20.5%, respectively), while the hepatitis A vaccine and the tetanus-diphtheria vaccine accounted for most routine vaccinations (18% and 14.2%, respectively). The rabies and the typhoid fever vaccines were administered inadequately to adolescents traveling to endemic areas. Malaria chemoprophylaxis should have been prescribed in many cases traveling to sub-Saharan Africa and the Indian subcontinent. CONCLUSIONS: Only a small number of adolescents from Greece traveling abroad seek pretravel counseling. We found significant gaps in typhoid fever and rabies vaccinations of adolescents traveling to endemic areas. We also found gaps in prescription of malaria chemoprophylaxis for those traveling to high-risk areas. There is a need to develop communication strategies to access adolescent travelers and improve appropriate vaccination and use of malaria chemoprophylaxis.


Assuntos
Quimioprevenção , Malária/prevenção & controle , Viagem , Vacinação/estatística & dados numéricos , Adolescente , África Subsaariana , Antimaláricos/uso terapêutico , Criança , Feminino , Grécia , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , América do Norte , Estudos Prospectivos , Vacina Antirrábica/administração & dosagem , Inquéritos e Questionários , Vacinas Tíficas-Paratíficas/administração & dosagem , Vacina contra Febre Amarela/administração & dosagem
9.
Travel Med Infect Dis ; 21: 69-73, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28774810

RESUMO

BACKGROUND: The number of adolescents who travel has increased. We estimated the preparedness of adolescents (12-18 years) departing from Athens to Africa and Asia. METHODS: An airport-based survey was conducted from 2011 to 2015. RESULTS: Sixty-eight adolescents participated; 27/68 (40%) had the Greek nationality. Their main destinations were the Indian subcontinent (37%) and South-East Asia (32%). Most adolescents planned to stay for <1 month (69%) or for 1-3 months (22%). Their main purpose for travel was to visit friends and relatives (VFRs) (60%). Compared to non-VFR adolescents, VFRs more frequently travelled to sub-Saharan Africa and Southeast Asia, stayed in local residences and for longer periods. Twenty-one (31%) adolescents sought pre-travel counseling (in 57% of cases 8-14 days before departure). Having the Greek nationality was the only significant factor associated with an increased probability for seeking pre-travel counseling. Vaccination against rabies, typhoid fever, Japanese encephalitis and meningococcus was highly inadequate for adolescents travelling to endemic areas. Significant gaps in malaria chemoprophylaxis were found in those travelling to the Indian subcontinent. CONCLUSIONS: Less than one third of adolescents travelling to Africa and Asia seek counseling. There is a need to access adolescent travellers in Greece and improve pre-travel vaccinations and malaria chemoprophylaxis.


Assuntos
Aeroportos , Inquéritos e Questionários , Viagem/estatística & dados numéricos , Adolescente , África Subsaariana , Ásia , Quimioprevenção/estatística & dados numéricos , Criança , Feminino , Grécia , Humanos , Masculino , Estudos Prospectivos , Doença Relacionada a Viagens , Vacinação/estatística & dados numéricos
10.
Expert Rev Anti Infect Ther ; 15(11): 1015-1025, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-29027495

RESUMO

INTRODUCTION: The past decade the Middle East and Southeastern Europe have witnessed an enormous movement of refugees due to the Syrian war and conflicts in Asia and Africa. Although carriage of and infections with multi-drug resistant (MDR) pathogens in refugees have been reported, pediatric data are scarce. Areas covered: MDR bacterial carriage and infections, and MDR-tuberculosis (TB) in refugee children from 2010. Expert commentary: High MDR carriage rates in refugee children are attributed to high pre-civil war MDR rates, war-damaged infrastructure and healthcare systems, and poor hygiene conditions. Currently there are no international guidelines about MDR screening in refugee children. Given the medical importance of MDRs, challenging therapeutics and risk of importation in non/low-endemic countries, we recommend routine screening and contact isolation upon hospitalization of refugees. TB, including MDR-TB, is highly-endemic in many Asian and African countries, however, current data in refugee children are lacking. TB Screening in refugees is widely implemented but there is no consensus on methods and target populations. Coordinated TB detection and treatment, use of rapid molecular tests and drug-susceptibility testing, better access to healthcare, cross border TB care collaboration, and protection from deportation while on treatment should be integrated parts of TB control and prevention.


Assuntos
Infecções Bacterianas/diagnóstico , Farmacorresistência Bacteriana Múltipla , Programas de Rastreamento/organização & administração , Refugiados , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Adolescente , África/epidemiologia , Antituberculosos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/epidemiologia , Infecções Bacterianas/microbiologia , Criança , Emigração e Imigração/estatística & dados numéricos , Europa (Continente)/epidemiologia , Humanos , Oriente Médio/epidemiologia , Guias de Prática Clínica como Assunto , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia , Tuberculose Resistente a Múltiplos Medicamentos/microbiologia
11.
Acta Paediatr ; 106(2): 288-291, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27862309

RESUMO

AIM: Data about immunisation rates in cystic fibrosis (CF) patients are scarce. We estimated the rates and timeliness of immunisations in CF patients aged 0.55-22 years. METHODS: We studied 122 subjects at a hospital in Greece in 2014. A standard questionnaire was used to collect data and parents' opinions about immunisations. RESULTS: The complete immunisation rates were 92.6% for diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-Haemophilus influenzae (DTaP-IPV-Hib), 96.7% for hepatitis A, 97.4% for hepatitis B, 97.4% for measles-mumps-rubella, 85.1% for the varicella zoster virus, 85.1% for the meningococcus C conjugate, 84.3% for the pneumococcus conjugate and 58.9% for the bacillus Calmette-Guérin vaccine. Immunisation rates in youths were 64.4% for DTaP-IPV, 26.8% for the tetravalent meningococcus conjugate vaccine and 54.1% for the human papilloma virus vaccine. In addition, 30.1% received the 23-valent pneumococcal polysaccharide vaccine and 45.6% received annual influenza vaccines. Complete, up-to-date immunisation rates fell from 61.4% at 12 months of age to 14.5% at six and 12 years. All vaccines experienced delays. Most parents believed vaccines were necessary to protect their child's health. CONCLUSION: Our study of children with CF found immunisation gaps with no catch-up immunisations and these need to be administered at follow-up visits.


Assuntos
Fibrose Cística , Imunização/estatística & dados numéricos , Adolescente , Criança , Pré-Escolar , Feminino , Grécia , Humanos , Lactente , Masculino , Adulto Jovem
12.
J Chemother ; 26(6): 375-8, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24621168

RESUMO

The objective of this study is to investigate antibiotic prescription practices among hospital-based physicians in Greece, using the 2007 national guidelines as the golden standard. A total of 168 physicians participated. Compliance rate with the first-line antibiotic treatment recommended by the national guidelines was 65·5% for acute bacterial sinusitis; 24% for acute uncomplicated cystitis; 36·4% for an acute febrile diarrheic syndrome; 38% for an afebrile adult with chronic obstructive pulmonary disease and non-productive cough of 7 days duration; 23·2% for streptococcal pharyngotonsillitis; 55·1% for a surgically sutured, dirty wound; and 48·2% for community-acquired pneumonia. The total mean rate of compliance with the first recommended antibiotic was 41·2%.


Assuntos
Antibacterianos/uso terapêutico , Uso de Medicamentos , Adulto , Idoso , Custos de Medicamentos , Feminino , Humanos , Conhecimento , Masculino , Pessoa de Meia-Idade , Médicos , Atenção Terciária à Saúde
13.
Am J Infect Control ; 41(1): 66-70, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22709989

RESUMO

BACKGROUND: The aim of this study was to assess the attitudes regarding mandatory occupational vaccinations and the vaccination coverage against vaccine-preventable diseases among health care workers (HCWs) working in primary health care centers in Greece. METHODS: A standardized questionnaire was distributed to HCWs working in all primary health care centers in Greece (n = 185). RESULTS: A total of 2,055 of 5,639 HCWs (36.4% response rate) from 152 primary health care centers participated. The self-reported completed vaccination rates were 23.3% against measles, 23.3% against mumps, 29.8% against rubella, 3% against varicella, 5.8% against hepatitis A, 55.7% against hepatitis B, and 47.3% against tetanus-diphtheria; corresponding susceptibility rates were 17%, 25%, 18.6%, 16.7%, 87.5%, 35%, and 52.6%. Mandatory vaccinations were supported by 65.1% of 1,807 respondents, with wide differences by disease. Multiple logistic regression analysis revealed higher rates of acceptance of mandatory vaccination in physicians compared with other HCW categories. CONCLUSIONS: Despite the fact that two-thirds of HCWs working in primary health care centers in Greece support mandatory vaccination for HCWs, completed vaccination rates against vaccine-preventable diseases are suboptimal.


Assuntos
Atitude do Pessoal de Saúde , Pessoal de Saúde , Programas Obrigatórios , Doenças Profissionais/prevenção & controle , Atenção Primária à Saúde , Vacinação/métodos , Vacinação/psicologia , Adulto , Uso de Medicamentos/estatística & dados numéricos , Feminino , Grécia , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Vacinação/estatística & dados numéricos , Adulto Jovem
14.
Travel Med Infect Dis ; 10(3): 135-9, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22521600

RESUMO

The aim of this study was to describe the children who seek pre-travel advice in Greece. During 2008-2010, 4065 persons sought pre-travel services in the 57 Prefectures, including 128 (3.15%) children <15 years. Main travel destinations were sub-Saharan Africa (54 children; 42.2%), South America (18; 14.1%), the Middle East (16; 12.5%), the Indian subcontinent (12; 9.4%), and South East Asia (7; 5.5%). Seventy-six children (59.4%) stayed for <1 month, 34 (26.6%) for 1-6 months, and 10 (7.8%) for >6 months. Recreation was the main purpose of travel (81 children; 63.3%), followed by work (24; 18.8%), and to visit friends and relatives (VFRs) (14; 10.9%). Paediatric travellers VFRs stayed more frequently in local residences compared to non-VFR paediatric travellers (85.7% and 20.2%). Children stayed more frequently in local residences and travelled more frequently for recreational purposes or to VFRs (27.3%, 63.3%, and 10.9%, respectively), compared to older travellers (11.9%, 58.8%, and 4%, respectively). Malaria chemoprophylaxis was prescribed for 64.8% of children travelling to sub-Saharan Africa. This study demonstrated clearly that only a very small number of international paediatric travellers seek pre-travel services in Greece. Communication strategies to access paediatric travellers should be developed in order to improve travel medicine services for children in Greece.


Assuntos
Antimaláricos/uso terapêutico , Quimioprevenção/métodos , Malária/prevenção & controle , Medicina de Viagem/métodos , Viagem , Vacinação/métodos , Adolescente , Criança , Pré-Escolar , Feminino , Grécia , Educação em Saúde/métodos , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Lactente , Masculino , Educação de Pacientes como Assunto/métodos
15.
Pediatr Infect Dis J ; 31(6): 623-5, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22333705

RESUMO

We studied the attitudes with regard to occupational vaccines and vaccination coverage among healthcare workers in pediatric departments. Completed vaccination rates were 33%, 33%, 41.7%, 3%, 5.8%, 69.2% and 36.3% against measles, mumps, rubella, varicella, hepatitis A, hepatitis B and tetanus-diphtheria, respectively. Susceptibility rates were 14.2%, 15.7%, 14.6%, 7.6%, 87.4%, 22.6% and 61.8% for measles, mumps, rubella, varicella, hepatitis A, hepatitis B and tetanus-diphtheria, respectively. Mandatory vaccinations were supported by 70.6% of healthcare workers, with considerable differences by target disease.


Assuntos
Atitude do Pessoal de Saúde , Infecções Bacterianas/prevenção & controle , Pessoal de Saúde , Doenças Profissionais/prevenção & controle , Vacinação/estatística & dados numéricos , Vacinas/administração & dosagem , Viroses/prevenção & controle , Adulto , Feminino , Grécia , Hospitais Pediátricos , Humanos , Masculino , Pessoa de Meia-Idade
16.
Pediatr Infect Dis J ; 31(5): 527-9, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22209917

RESUMO

Oseltamivir was administered at 1.0 mg/kg b.i.d. to 13 neonates exposed to influenza H1N1. No influenza, neurologic, or laboratory adverse effects occurred. The mean Cmax values for oseltamivir and oseltamivir carboxylate were found to be lower than those reported for children 1 to 5 years old, whereas Tmax values were similar to children 1 to 5 years old. Age and gender were found to significantly affect oseltamivir clearance.


Assuntos
Antivirais/efeitos adversos , Antivirais/farmacocinética , Vírus da Influenza A Subtipo H1N1 , Influenza Humana/prevenção & controle , Oseltamivir/efeitos adversos , Oseltamivir/farmacocinética , Antivirais/uso terapêutico , Quimioprevenção , Feminino , Humanos , Recém-Nascido , Influenza Humana/virologia , Masculino , Oseltamivir/análogos & derivados , Oseltamivir/uso terapêutico
17.
Am J Infect Control ; 40(1): 75-7, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21737177
18.
Travel Med Infect Dis ; 8(3): 161-8, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20541136

RESUMO

Among all travel-acquired illnesses, malaria carries the greatest burden not only considering the number of imported cases but also the potential of a fatal outcome. The increased number of imported malaria cases in developed countries in the last decades has been attributed to the increasing number of travel to tropical destinations in combination with the enormous influx of immigrants. At present, immigrants visiting friends and relatives (VFRs) constitute the most significant group of travellers for malaria importation in developed countries, with sub-Saharan Africa destinations carrying the highest risk. VFRs typically demonstrate travel and behavioural patterns which render them at high risk for acquisition of this largely preventable infection. Pre-travel services are rarely sought by VFRs, whereas misconceptions that they possess life-long immunity against malaria make them less likely to receive or adhere to antimalarial chemoprophylaxis recommendations. There is an urgent need to increase awareness about malaria of this group of travellers.


Assuntos
Malária/epidemiologia , Viagem , Antimaláricos , Quimioprevenção , Países em Desenvolvimento/estatística & dados numéricos , Emigrantes e Imigrantes/estatística & dados numéricos , Família , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Malária/prevenção & controle , Malária/transmissão
19.
Lancet Infect Dis ; 9(5): 301-11, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19393960

RESUMO

The European Network for Infectious Diseases (EUNID) is a network of clinicians, public health epidemiologists, microbiologists, infection control, and critical-care doctors from the European member states, who are experienced in the management of patients with highly infectious diseases. We aim to develop a consensus recommendation for infection control during clinical management and invasive procedures in such patients. After an extensive literature review, draft recommendations were amended jointly by 27 partners from 15 European countries. Recommendations include repetitive training of staff to ascertain infection control, systematic use of cough and respiratory etiquette at admission to the emergency department, fluid sampling in the isolation room, and analyses in biosafety level 3/4 laboratories, and preference for point-of-care bedside laboratory tests. Children should be cared for by paediatricians and intensive-care patients should be cared for by critical-care doctors in high-level isolation units (HLIU). Invasive procedures should be avoided if unnecessary or done in the HLIU, as should chest radiography, ultrasonography, and renal dialysis. Procedures that require transport of patients out of the HLIU should be done during designated sessions or hours in secure transport. Picture archiving and communication systems should be used. Post-mortem examination should be avoided; biopsy or blood collection is preferred.


Assuntos
Controle de Doenças Transmissíveis/normas , Surtos de Doenças/prevenção & controle , Controle de Infecções/normas , Isolamento de Pacientes , Isoladores de Pacientes/normas , Adulto , Criança , Controle de Doenças Transmissíveis/métodos , Serviço Hospitalar de Emergência/normas , Europa (Continente)/epidemiologia , Humanos , Controle de Infecções/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA